Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Small Cell Lung Carcinoma 16 Uterine Cervical Neoplasms 15 Ovarian Neoplasms 10 Oropharyngeal Neoplasms 10 Carcinoma 9 Urinary Bladder Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Fallopian Tube Neoplasms 8 Stomach Neoplasms 7 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Breast Neoplasms 6 Adenocarcinoma of Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Medulloblastoma 5 Cholangiocarcinoma 5 Prostatic Neoplasms 4 Neuroblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Urethral Neoplasms 3

Interventions

Ifosfamide 27 Methotrexate 23 Doxorubicin 21 Cyclophosphamide 20 Cisplatin 19 Filgrastim 15 Etoposide 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Specimen Handling 9 Granulocyte Colony-Stimulating Factor 8 fludarabine 7 Zoledronic Acid 7 X-Rays 7 Sirolimus 7 Nivolumab 7 Neoadjuvant Therapy 7 Irinotecan 7 Docetaxel 7 Carboplatin 7 Biopsy 7 apatinib 6 Phantoms, Imaging 6 Mesna 6 cabozantinib 5 Vincristine 5 Topotecan 5 Radiotherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡